![2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care - Primary Care Diabetes 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care - Primary Care Diabetes](https://www.primary-care-diabetes.com/cms/asset/6cf5b5b7-0177-4cb4-b7f4-487708d668bf/gr1.jpg)
2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care - Primary Care Diabetes
![Two popular diabetes drugs outperformed others in large clinical trial | National Institutes of Health (NIH) Two popular diabetes drugs outperformed others in large clinical trial | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2022/20220921-infographic.jpg)
Two popular diabetes drugs outperformed others in large clinical trial | National Institutes of Health (NIH)
![Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01803-5/MediaObjects/41591_2022_1803_Fig1_HTML.png)
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine
![Cureus | Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus Cureus | Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus](https://assets.cureus.com/uploads/figure/file/180830/lightbox_5825e54059c511eb9eb2930f689bfa82-Figure-3.png)
Cureus | Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
![Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01202-5/MediaObjects/12933_2020_1202_Fig1_HTML.png)
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text
![Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management | Cardiovascular Diabetology | Full Text Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-019-0860-y/MediaObjects/12933_2019_860_Fig1_HTML.png)
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management | Cardiovascular Diabetology | Full Text
![IMPORTANCE OF METFORMIN WITH REPAGLINIDE IN THE TREATMENT OF TYPE II DIABETES MELLITUS: A DECADEL REVIEW | Semantic Scholar IMPORTANCE OF METFORMIN WITH REPAGLINIDE IN THE TREATMENT OF TYPE II DIABETES MELLITUS: A DECADEL REVIEW | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b264e41c261fa466fe993c82e15abc1f53ef11c4/2-Figure1-1.png)
IMPORTANCE OF METFORMIN WITH REPAGLINIDE IN THE TREATMENT OF TYPE II DIABETES MELLITUS: A DECADEL REVIEW | Semantic Scholar
![Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes? - The Lancet Diabetes & Endocrinology Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes? - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/2019126433/2039338139/gr1.jpg)